Table 1

Annual prevalence of systemic glucocorticoid (GC) prescription users in Denmark, 1999–2015, overall and stratified by sex and age group

Prevalence of prescription users (% of the national population)
AllSexAge groups (years)
WomenMen0–45–910–1415–1920–3940–6465–7980+
19993.23.42.90.060.10.20.92.23.88.18.4
20003.33.63.00.060.10.21.02.43.98.18.7
20013.33.63.00.090.10.21.02.43.98.28.8
20023.33.63.00.060.10.31.12.63.98.18.9
20033.23.52.90.070.10.21.02.33.88.08.9
20043.23.52.90.060.10.20.92.33.88.08.9
20053.33.63.00.060.10.21.02.53.88.09.2
20063.43.73.00.070.10.31.12.54.08.09.3
20073.43.73.10.070.10.31.22.64.08.09.4
20083.43.73.10.070.10.31.22.63.97.79.5
20093.33.63.00.080.10.31.12.43.97.79.5
20103.33.62.90.070.10.21.02.23.87.69.7
20113.23.52.90.080.10.21.02.13.77.49.7
20123.13.42.80.070.10.20.92.03.67.29.7
20133.13.42.80.080.10.20.81.93.57.110
20143.13.42.80.070.10.20.81.93.57.09.8
20153.03.32.70.070.10.20.71.73.37.09.9
  • Reference group for all systemic GCs is all members of the Danish population as of 1 January in the year of interest. Reference groups for the stratified results are all members in the subpopulation of interest as of 1 January of each year.